Process View
The network for 'response to increased oxygen levels' in your query organism is displayed on the left, if relationships are supported by the integrated data. Moving any of the genes in that network will simultaneously update the homologs in the networks displayed to the right (if they exist). Additionally, hovering over any nodes will highlight the identified functionally similar homologs in the other networks. Last, the bar above the networks allows you to remove/add additional organisms. Simily drag and drop the organism names in the desired order.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting an increase in the level of oxygen.
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
Col1a1 | collagen, type I, alpha 1 | 0.905 | |
Col3a1 | collagen, type III, alpha 1 | 0.384 | |
Col12a1 | collagen, type XII, alpha 1 | 0.332 | |
Bgn | biglycan | 0.254 | |
Egr2 | early growth response 2 | 0.226 | |
Col1a2 | collagen, type I, alpha 2 | 0.226 | |
Nr4a1 | nuclear receptor subfamily 4, group A, member 1 | 0.138 | |
Col5a1 | collagen, type V, alpha 1 | 0.128 | |
COX3 | cytochrome c oxidase subunit 3 | 0.122 | |
LOC305103 | cell surface glycoprotein gp42 | 0.108 | |
Csf3 | colony stimulating factor 3 (granulocyte) | 0.101 | |
Tpo | thyroid peroxidase | 0.096 | |
RT1-M5 | RT1 class Ib, locus M5 | 0.093 | |
Serpina5 | serine (or cysteine) peptidase inhibitor, clade A, member 5 | 0.082 | |
Eln | elastin | 0.078 | |
Loxl1 | lysyl oxidase-like 1 | 0.077 | |
Mas1 | MAS1 oncogene | 0.075 | |
Acvrl1 | activin A receptor type II-like 1 | 0.070 | |
Tbxa2r | thromboxane A2 receptor | 0.068 | |
Tnf | tumor necrosis factor (TNF superfamily, member 2) | 0.064 | |
Chrm1 | cholinergic receptor, muscarinic 1 | 0.064 | |
Fos | FBJ osteosarcoma oncogene | 0.064 | |
Phex | phosphate regulating endopeptidase homolog, X-linked | 0.064 | |
Ccl4 | chemokine (C-C motif) ligand 4 | 0.063 | |
Rhoj | ras homolog gene family, member J | 0.062 | |
Cacna1g | calcium channel, voltage-dependent, T type, alpha 1G subunit | 0.057 | |
Prl2b1 | Prolactin family 2, subfamily b, member 1 | 0.054 | |
Adora2a | adenosine A2a receptor | 0.054 | |
Aebp1 | AE binding protein 1 | 0.053 | |
Lef1 | lymphoid enhancer binding factor 1 | 0.053 | |
LOC100361569 | mage-d3-like | 0.053 | |
S1pr2 | sphingosine-1-phosphate receptor 2 | 0.051 | |
Tpsab1 | tryptase alpha/beta 1 | 0.050 | |
Ankrd1 | ankyrin repeat domain 1 (cardiac muscle) | 0.050 | |
Cd4 | Cd4 molecule | 0.049 | |
Lipogenin | Lipogenin | 0.049 | |
Col5a2 | collagen, type V, alpha 2 | 0.048 | |
Cd44 | Cd44 molecule | 0.048 | |
Pla1a | phospholipase A1 member A | 0.047 | |
Zp3 | zona pellucida glycoprotein 3 (sperm receptor) | 0.047 | |
Postn | periostin, osteoblast specific factor | 0.046 | |
Mmp7 | matrix metallopeptidase 7 | 0.045 | |
Col14a1 | collagen, type XIV, alpha 1 | 0.045 | |
Pdgfrb | platelet derived growth factor receptor, beta polypeptide | 0.045 | |
Fn1 | fibronectin 1 | 0.045 | |
Fstl1 | follistatin-like 1 | 0.044 | |
Aqp2 | aquaporin 2 (collecting duct) | 0.043 | |
Foxd3 | forkhead box D3 | 0.042 | |
Col15a1 | collagen, type XV, alpha 1 | 0.042 | |
Egr1 | early growth response 1 | 0.042 | |
Ncf1 | neutrophil cytosolic factor 1 | 0.042 | |
Ttll3 | tubulin tyrosine ligase-like family, member 3 | 0.042 | |
Adam6 | a disintegrin and metallopeptidase domain 6 | 0.042 | |
Col10a1 | collagen, type X, alpha 1 | 0.041 | |
Junb | jun B proto-oncogene | 0.041 | |
G6pc | glucose-6-phosphatase, catalytic subunit | 0.041 | |
Plcb2 | phospholipase C, beta 2 | 0.040 | |
Rup2 | urinary protein 2 | 0.040 | |
Pcolce | procollagen C-endopeptidase enhancer | 0.039 | |
Dab2 | disabled homolog 2 (Drosophila) | 0.039 | |
Gpr20 | G protein-coupled receptor 20 | 0.039 | |
Ccr2 | chemokine (C-C motif) receptor 2 | 0.039 | |
S100b | S100 calcium binding protein B | 0.038 | |
Arpp21 | cAMP-regulated phosphoprotein 21 | 0.038 | |
Serpinh1 | serine (or cysteine) peptidase inhibitor, clade H, member 1 | 0.038 | |
COX1 | cytochrome c oxidase subunit 1 | 0.037 | |
Crx | cone-rod homeobox | 0.037 | |
Plau | plasminogen activator, urokinase | 0.037 | |
Gata1 | GATA binding protein 1 | 0.037 | |
Gckr | glucokinase (hexokinase 4) regulator | 0.036 | |
Mmp8 | matrix metallopeptidase 8 | 0.036 | |
Gpc3 | glypican 3 | 0.036 | |
Icam1 | intercellular adhesion molecule 1 | 0.036 | |
Ypel5 | yippee-like 5 (Drosophila) | 0.035 | |
Gna15 | guanine nucleotide binding protein, alpha 15 | 0.035 | |
Igfals | insulin-like growth factor binding protein, acid labile subunit | 0.035 | |
LOC100361445 | mCG7602-like | 0.034 | |
Lox | lysyl oxidase | 0.034 | |
Itgad | integrin, alpha D | 0.034 | |
Lum | lumican | 0.033 | |
Irs1 | insulin receptor substrate 1 | 0.033 | |
Grm4 | glutamate receptor, metabotropic 4 | 0.033 | |
Onecut1 | one cut homeobox 1 | 0.033 | |
Col9a2 | collagen, type IX, alpha 2 | 0.033 | |
Cel | carboxyl ester lipase | 0.033 | |
Plaur | plasminogen activator, urokinase receptor | 0.033 | |
Psgb1 | pregnancy-specific beta 1-glycoprotein | 0.033 | |
Scnn1a | sodium channel, nonvoltage-gated 1 alpha | 0.032 | |
Prm3 | protamine 3 | 0.032 | |
Kcns1 | potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 | 0.032 | |
Cxcl1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.032 | |
Kcnj8 | potassium inwardly-rectifying channel, subfamily J, member 8 | 0.031 | |
Cdx1 | caudal type homeo box 1 | 0.031 | |
Cpz | carboxypeptidase Z | 0.031 | |
Fkbp10 | FK506 binding protein 10 | 0.031 | |
Acads | acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain | 0.031 | |
Teddm1 | transmembrane epididymal protein 1 | 0.030 | |
Slc7a13 | solute carrier family 7, (cationic amino acid transporter, y+ system) member 13 | 0.030 | |
Tcrb | T-cell receptor beta chain | 0.030 | |
LOC686539 | similar to immunoglobulin superfamily containing leucine-rich repeat | 0.030 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.955 | |
NOSTRIN | nitric oxide synthase trafficker | 0.942 | |
FADD | Fas (TNFRSF6)-associated via death domain | 0.929 | |
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.921 | |
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.906 | |
TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.868 | |
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.850 | |
FAS | Fas (TNF receptor superfamily, member 6) | 0.655 | |
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.574 | |
COTL1 | coactosin-like 1 (Dictyostelium) | 0.529 | |
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.511 | |
PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.510 | |
PLAU | plasminogen activator, urokinase | 0.469 | |
TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.462 | |
PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.435 | |
CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.389 | |
PLAUR | plasminogen activator, urokinase receptor | 0.371 | |
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.291 | |
AR | androgen receptor | 0.288 | |
ALDH1A1 | aldehyde dehydrogenase 1 family, member A1 | 0.285 | |
PTEN | phosphatase and tensin homolog | 0.249 | |
HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.248 | |
THBS1 | thrombospondin 1 | 0.238 | |
NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.236 | |
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.235 | |
PDGFA | platelet-derived growth factor alpha polypeptide | 0.223 | |
PLAT | plasminogen activator, tissue | 0.218 | |
CCL5 | chemokine (C-C motif) ligand 5 | 0.215 | |
TRADD | TNFRSF1A-associated via death domain | 0.203 | |
PDGFC | platelet derived growth factor C | 0.187 | |
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | 0.184 | |
COL6A1 | collagen, type VI, alpha 1 | 0.182 | |
KAT2B | K(lysine) acetyltransferase 2B | 0.169 | |
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.149 | |
CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.144 | |
TGFB1 | transforming growth factor, beta 1 | 0.142 | |
COL1A2 | collagen, type I, alpha 2 | 0.139 | |
NCOA2 | nuclear receptor coactivator 2 | 0.128 | |
BMP1 | bone morphogenetic protein 1 | 0.121 | |
A2M | alpha-2-macroglobulin | 0.119 | |
FGFR1 | fibroblast growth factor receptor 1 | 0.114 | |
UHRF1 | ubiquitin-like with PHD and ring finger domains 1 | 0.108 | |
TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.107 | |
SNAI1 | snail homolog 1 (Drosophila) | 0.106 | |
IGFBP3 | insulin-like growth factor binding protein 3 | 0.099 | |
BID | BH3 interacting domain death agonist | 0.097 | |
EGFR | epidermal growth factor receptor | 0.096 | |
ENG | endoglin | 0.094 | |
DAXX | death-domain associated protein | 0.091 | |
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.091 | |
HDAC2 | histone deacetylase 2 | 0.090 | |
ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.089 | |
COL4A1 | collagen, type IV, alpha 1 | 0.085 | |
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.085 | |
F2R | coagulation factor II (thrombin) receptor | 0.077 | |
CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.075 | |
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.070 | |
ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.069 | |
PTPRF | protein tyrosine phosphatase, receptor type, F | 0.067 | |
PRKCDBP | protein kinase C, delta binding protein | 0.063 | |
CCR1 | chemokine (C-C motif) receptor 1 | 0.062 | |
FHL2 | four and a half LIM domains 2 | 0.058 | |
TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.058 | |
NRP1 | neuropilin 1 | 0.057 | |
COL1A1 | collagen, type I, alpha 1 | 0.055 | |
THBS2 | thrombospondin 2 | 0.053 | |
ESR1 | estrogen receptor 1 | 0.050 | |
CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.050 | |
ALOX5AP | arachidonate 5-lipoxygenase-activating protein | 0.050 | |
TXNRD1 | thioredoxin reductase 1 | 0.049 | |
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.049 | |
COL3A1 | collagen, type III, alpha 1 | 0.048 | |
COL7A1 | collagen, type VII, alpha 1 | 0.048 | |
TUBB6 | tubulin, beta 6 | 0.046 | |
NCOA1 | nuclear receptor coactivator 1 | 0.045 | |
RUNX1 | runt-related transcription factor 1 | 0.045 | |
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.044 | |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | 0.044 | |
HTT | huntingtin | 0.042 | |
ORM1 | orosomucoid 1 | 0.041 | |
TAF1D | TATA box binding protein (TBP)-associated factor, RNA polymerase I, D, 41kDa | 0.041 | |
CAV2 | caveolin 2 | 0.038 | |
PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.038 | |
SPHK1 | sphingosine kinase 1 | 0.038 | |
NGEF | neuronal guanine nucleotide exchange factor | 0.037 | |
SMARCD3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 | 0.036 | |
NCOA6 | nuclear receptor coactivator 6 | 0.035 | |
FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.035 | |
DYNLT1 | dynein, light chain, Tctex-type 1 | 0.035 | |
SFTPD | surfactant protein D | 0.035 | |
MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.035 | |
S100A8 | S100 calcium binding protein A8 | 0.034 | |
GJA1 | gap junction protein, alpha 1, 43kDa | 0.034 | |
TTR | transthyretin | 0.033 | |
SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.033 | |
ESRRG | estrogen-related receptor gamma | 0.032 | |
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.031 | |
FZD1 | frizzled homolog 1 (Drosophila) | 0.031 | |
PTAFR | platelet-activating factor receptor | 0.030 | |
CD59 | CD59 molecule, complement regulatory protein | 0.030 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
Trp53 | transformation related protein 53 | 0.938 | |
Nos3 | nitric oxide synthase 3, endothelial cell | 0.927 | |
Lepr | leptin receptor | 0.845 | |
Ptgs2 | prostaglandin-endoperoxide synthase 2 | 0.743 | |
Apoe | apolipoprotein E | 0.722 | |
Csf1 | colony stimulating factor 1 (macrophage) | 0.715 | |
Cav1 | caveolin 1, caveolae protein | 0.712 | |
Mmp9 | matrix metallopeptidase 9 | 0.660 | |
Pten | phosphatase and tensin homolog | 0.603 | |
Lep | leptin | 0.596 | |
Lyz2 | lysozyme 2 | 0.394 | |
Col1a1 | collagen, type I, alpha 1 | 0.384 | |
Itgb1 | integrin beta 1 (fibronectin receptor beta) | 0.334 | |
Vegfa | vascular endothelial growth factor A | 0.296 | |
Vhl | von Hippel-Lindau tumor suppressor | 0.289 | |
Ldlr | low density lipoprotein receptor | 0.282 | |
Apc | adenomatosis polyposis coli | 0.248 | |
Vdr | vitamin D receptor | 0.241 | |
Tlr4 | toll-like receptor 4 | 0.239 | |
Cebpa | CCAAT/enhancer binding protein (C/EBP), alpha | 0.237 | |
Plat | plasminogen activator, tissue | 0.230 | |
Ccl2 | chemokine (C-C motif) ligand 2 | 0.229 | |
Cd44 | CD44 antigen | 0.170 | |
Selp | selectin, platelet | 0.157 | |
Col4a3 | collagen, type IV, alpha 3 | 0.139 | |
Nos2 | nitric oxide synthase 2, inducible | 0.124 | |
Cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 0.120 | |
Tgfb1 | transforming growth factor, beta 1 | 0.119 | |
Lmna | lamin A | 0.119 | |
Ghr | growth hormone receptor | 0.115 | |
Pparg | peroxisome proliferator activated receptor gamma | 0.099 | |
Nos1 | nitric oxide synthase 1, neuronal | 0.085 | |
Ccr2 | chemokine (C-C motif) receptor 2 | 0.081 | |
Tgfbr2 | transforming growth factor, beta receptor II | 0.078 | |
Il10 | interleukin 10 | 0.075 | |
Fbn1 | fibrillin 1 | 0.070 | |
Fos | FBJ osteosarcoma oncogene | 0.066 | |
Il6st | interleukin 6 signal transducer | 0.066 | |
Kiss1 | KiSS-1 metastasis-suppressor | 0.065 | |
Notch1 | Notch gene homolog 1 (Drosophila) | 0.064 | |
Spp1 | secreted phosphoprotein 1 | 0.062 | |
Alox5ap | arachidonate 5-lipoxygenase activating protein | 0.061 | |
Hif1a | hypoxia inducible factor 1, alpha subunit | 0.058 | |
Gja1 | gap junction protein, alpha 1 | 0.054 | |
Notch2 | Notch gene homolog 2 (Drosophila) | 0.053 | |
Agtr2 | angiotensin II receptor, type 2 | 0.053 | |
Ar | androgen receptor | 0.051 | |
Ifng | interferon gamma | 0.051 | |
Cebpb | CCAAT/enhancer binding protein (C/EBP), beta | 0.047 | |
Ltbp3 | latent transforming growth factor beta binding protein 3 | 0.042 | |
Ifngr1 | interferon gamma receptor 1 | 0.039 | |
Esr1 | estrogen receptor 1 (alpha) | 0.039 | |
Lif | leukemia inhibitory factor | 0.038 | |
Kit | kit oncogene | 0.037 | |
Ctsk | cathepsin K | 0.035 | |
Tlr2 | toll-like receptor 2 | 0.035 | |
Ahr | aryl-hydrocarbon receptor | 0.035 | |
Tnfrsf1a | tumor necrosis factor receptor superfamily, member 1a | 0.034 | |
Fcgr2b | Fc receptor, IgG, low affinity IIb | 0.034 | |
Il6 | interleukin 6 | 0.033 | |
Prkch | protein kinase C, eta | 0.033 | |
Prx | periaxin | 0.032 | |
Agtr1a | angiotensin II receptor, type 1a | 0.029 | |
Gnas | GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus | 0.029 | |
Cyr61 | cysteine rich protein 61 | 0.029 | |
Orai1 | ORAI calcium release-activated calcium modulator 1 | 0.027 | |
Fas | Fas (TNF receptor superfamily member 6) | 0.027 | |
Ppargc1a | peroxisome proliferative activated receptor, gamma, coactivator 1 alpha | 0.027 | |
Crim1 | cysteine rich transmembrane BMP regulator 1 (chordin like) | 0.027 | |
Tal1 | T-cell acute lymphocytic leukemia 1 | 0.027 | |
Pnpla2 | patatin-like phospholipase domain containing 2 | 0.026 | |
Ptrf | polymerase I and transcript release factor | 0.026 | |
Tgfb2 | transforming growth factor, beta 2 | 0.024 | |
Tmprss11e | transmembrane protease, serine 11e | 0.023 | |
Ctnnb1 | catenin (cadherin associated protein), beta 1 | 0.023 | |
Egr2 | early growth response 2 | 0.023 | |
Insr | insulin receptor | 0.022 | |
Kcne1 | potassium voltage-gated channel, Isk-related subfamily, member 1 | 0.022 | |
Tcf21 | transcription factor 21 | 0.022 | |
Plin1 | perilipin 1 | 0.021 | |
Wdfy2 | WD repeat and FYVE domain containing 2 | 0.021 | |
Sox13 | SRY-box containing gene 13 | 0.021 | |
Nfe2l2 | nuclear factor, erythroid derived 2, like 2 | 0.021 | |
Sele | selectin, endothelial cell | 0.021 | |
Pdgfb | platelet derived growth factor, B polypeptide | 0.020 | |
Smad3 | MAD homolog 3 (Drosophila) | 0.020 | |
Ptpn11 | protein tyrosine phosphatase, non-receptor type 11 | 0.020 | |
Ivd | isovaleryl coenzyme A dehydrogenase | 0.020 | |
Adipoq | adiponectin, C1Q and collagen domain containing | 0.020 | |
Nab2 | Ngfi-A binding protein 2 | 0.019 | |
Kl | klotho | 0.019 | |
Foxa2 | forkhead box A2 | 0.019 | |
Prkdc | protein kinase, DNA activated, catalytic polypeptide | 0.018 | |
Lama2 | laminin, alpha 2 | 0.018 | |
Slc9a3r2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.018 | |
Prdx1 | peroxiredoxin 1 | 0.018 | |
Cnn1 | calponin 1 | 0.018 | |
Amhr2 | anti-Mullerian hormone type 2 receptor | 0.018 | |
Hif1an | hypoxia-inducible factor 1, alpha subunit inhibitor | 0.017 | |
Rxra | retinoid X receptor alpha | 0.017 |